ÆäÀÌÁö À̹ÌÁö
PDF
ePub

KF27 G663

1993a

COMMITTEE ON GOVERNMENT OPERATIONS

JOHN CONYERS, JR., Michigan, Chairman

CARDISS COLLINS, Illinois
GLENN ENGLISH, Oklahoma
HENRY A. WAXMAN, California
MIKE SYNAR, Oklahoma

STEPHEN L. NEAL, North Carolina
TOM LANTOS, California
MAJOR R. OWENS, New York
EDOLPHUS TOWNS, New York

JOHN M. SPRATT, JR., South Carolina
GARY A. CONDIT, California
COLLIN C. PETERSON, Minnesota
KAREN L. THURMAN, Florida
BOBBY L. RUSH, Illinois

CAROLYN B. MALONEY, New York
THOMAS M. BARRETT, Wisconsin
DONALD M. PAYNE, New Jersey
FLOYD H. FLAKE, New York
JAMES A. HAYES, Louisiana
CRAIG A. WASHINGTON, Texas
BARBARA-ROSE COLLINS, Michigan
CORRINE BROWN, Florida

MARJORIE MARGOLIES-MEZVINSKY,
Pennsylvania

LYNN C. WOOLSEY, California

WILLIAM F. CLINGER, JR., Pennsylvania
AL MCCANDLESS, California

J. DENNIS HASTERT, Illinois
JON L. KYL, Arizona

CHRISTOPHER SHAYS, Connecticut
STEVEN SCHIFF, New Mexico
CHRISTOPHER COX, California
CRAIG THOMAS, Wyoming

ILEANA ROS-LEHTINEN, Florida

RONALD K. MACHTLEY, Rhode Island
DICK ZIMMER, New Jersey

WILLIAM H. ZELIFF, JR., New Hampshire

JOHN M. MCHUGH, New York
STEPHEN HORN, California
DEBORAH PRYCE, Ohio
JOHN L. MICA, Florida
ROB PORTMAN, Ohio

BERNARD SANDERS, Vermont (Independent)

[blocks in formation]

JOHN CONYERS, JR., Michigan

WILLIAM F. CLINGER, JR., Pennsylvania

RONALD A. STROMAN, Staff Director
WILLIAM M. LAYDEN, Professional Staff Member
BRENDA E. PILLORS, Professional Staff Member
MARTINE M. DICROCE, Clerk
MARTHA B. MORGAN, Minority Professional Staff

(II)

95-17548

CONTENTS

Page

Block, Gladys, Ph.D., University of California, Berkeley
Cordaro, J.B., president, Council for Responsible Nutrition

186

128

172

238

86

Hildwine, Regina, director, Technical Regulatory Affairs, National Food
Processors Association, accompanied by John Bode, legislative counsel ..
Huxtable, Ryan J., Ph.D., University of Arizona

Johnston, Richard, M.D., senior vice president, programs, and medical
director, March of Dimes Birth Defects Foundation

McCaleb, Robert S., Herb Research Foundation

McNamara, Stephen H., Hyman, Phelps & McNamara, P.C., on behalf

of the Utah Natural Products Alliance

Rosenberg, Irwin H., professor of medicine and nutrition, Tufts Univer-
sity

Shank, Fred R., Ph.D., Director, Center for Food Safety and Applied
Nutrition [CFSAN], Food and Drug Administration, accompanied by
Mitchell Zeller, Office of the Deputy Commissioner for Policy; Robert
Lake, Director, Office of Policy, Planning and Strategic Initiatives;
and Lori Love, Ph.D., Director, Clinical Research and Review Staff

Silverglade, Bruce, director, legal affairs, Center for Science in the Public

Interest

Stark, Shirley, assistant attorney general of New York

Sternberg, Esther M., M.D., Chief, Unit on Neuroendocrine Immunology

and Behavior, Clinical Neuroendocrinology Branch, National Institute

of Mental Health, National Institutes of Health

Towns, Hon. Edolphus, a Representative in Congress from the State

of New York, and chairman, Human Resources and Intergovernmental

Relations Subcommittee: Opening statement

Whittekin, Martie, president, National Nutritional Foods Association

Letters, statements, etc., submitted for the record by:

[ocr errors]

210

Hildwine, Regina, director, Technical Regulatory Affairs, National Food
Processors Association: Prepared statement

174

367

McCaleb, Robert S., Herb Research Foundation: Prepared statement
McNamara, Stephen H., Hyman, Phelps & McNamara, P.C., on behalf
of the Utah Natural Products Alliance: Prepared statement

Rosenberg, Irwin H., professor of medicine and nutrition, Tufts Univer-

sity: Prepared statement

44

Page

Letters, statements, etc., submitted for the record by-Continued

Stark, Shirley, assistant attorney general of New York: Prepared state

ment

Sternberg, Esther M., M.D., Chief, Unit on Neuroendocrine Immunology and Behavior, Clinical Neuroendocrinology Branch, National Institute of Mental Health, National Institutes of Health: Prepared statement .... Whittekin, Martie, president, National Nutritional Foods Association: Prepared statement

APPENDIXES

Appendix 1.-Answers from the scientists to questions from the Members
Appendix 2.-Additional statements and materials for the record

106

230

162

395

457

FEDERAL DRUG ADMINISTRATION'S REGULATION OF DIETARY SUPPLEMENTS

TUESDAY, JULY 20, 1993

HOUSE OF REPRESENTATIVES,

HUMAN RESOURCES AND

INTERGOVERNMENTAL RELATIONS SUBCOMMITTEE

OF THE COMMITTEE ON GOVERNMENT OPERATIONS,

Washington, DC.

The subcommittee met, pursuant to notice, at 10 a.m., in room 2247, Rayburn House Office Building, Hon. Edolphus Towns (chairman of the subcommittee) presiding.

Present: Representatives Edolphus Towns, Thomas M. Barrett, Donald M. Payne, Steven Schiff, Stephen Horn, and Bernard Sand

ers.

Also present: Ronald A. Stroman, staff director; William M. Layden and Brenda E. Pillors, professional staff members; Martine M. DiCroce, clerk; and Martha B. Morgan, minority professional staff, Committee on Government Operations.

OPENING STATEMENT OF CHAIRMAN TOWNS

Mr. Towns. The subcommittee will come to order.

Today's hearing is on the Food and Drug Administration's regulation of dietary supplements. As required by the Dietary Supplement Act of 1992, on June 15 of this year, FDA proposed regulations governing nutrition labeling and nutrient content, and health claims for all dietary supplements. FDA also asked for comments on how it should regulate dietary supplements. Whether FDA is striking the proper regulatory balance is the focus of this hearing today.

Millions of Americans regularly consume vitamins, minerals, herbs, and other dietary supplements to improve their nutrition and health. In recent years, growing scientific research has revealed that certain nutrients, such as vitamin E, may help to prevent heart disease and cancer. At a time when this country is trying to reduce health care costs and improve the health of all Americans, dietary supplements could contribute greatly to the prevention of disease.

At the same time, consumers have a right to expect that their dietary supplements are safe and manufactured to the highest standards possible. Consumers also have a right to expect that claims made about the health and nutritional benefits of dietary supplements are truthful and nonmisleading. Consumers are subject to a barrage of conflicting messages in the media about the po

(1)

tential health benefits and health risks of certain nutrient supplements.

We must all work together to avoid the tragedy that occurred in 1989 when a contaminated batch of L-tryptophan was linked to a deadly disease known as EMS. In 1991, this subcommittee, under the leadership of my predecessor, the late Honorable Ted Weiss, Democrat of New York, heard firsthand from some of the innocent persons who were harmed by L-tryptophan. Today we will have an opportunity to follow up on that initial inquiry.

It is time to cut through the regulatory fog surrounding dietary supplements and hear from the experts about: (1) FDA's actual and proposed regulations for dietary supplements; (2) the public health risk and benefits of dietary supplements; (3) the scientific data supporting health claims for dietary supplements; and (4) the proper regulatory balance between consumer protection and free trade.

I look forward to hearing from our witnesses this morning. Before we hear from our first witness, I would like to yield to Mr. Schiff, the ranking minority member of the subcommittee, for any remarks that he might have at this time.

Congressman Schiff.

Mr. SCHIFF. Thank you very much, Mr. Chairman. I will certainly be brief. We have a lot of qualified witnesses to hear from. I want to, first of all, thank you for holding this hearing. The subject of dietary supplements, I think, doesn't receive as much media attention as certain other issues we are seeing today. Nevertheless, I can tell you that from the volume of mail I receive from my constituents, there is obviously great public interest in this subject; and I want to thank you personally for holding this hearing. I am an original cosponsor of Congressman Bill Richardson's bill, H.R. 1709, which we believe will strike a balance-the balance that you referred to-between the responsibility of the FDA to look after those substances which we consume and the right of people to select dietary supplements if they choose to do so without interference from the government that goes beyond the government's legitimate interest in protecting public health and safety.

I would be interested, from any or all of the witnesses in the course of their testimony, if they happen to be familiar with H.R. 1709, if they would express their support or nonsupport, if that is the case, of that bill. We, the sponsors, believe that we are achieving the correct balance, but I would be interested in other views on that.

And with that, I want to, again, say that I think this is a very important hearing; and I look forward to it. And I yield back. Mr. Towns. Thank you very much.

Congressman Sanders.

Mr. SANDERS. Thank you Mr. Chairman. I will also be brief. This is an extremely important hearing and, as Congressman Schiff has mentioned, has generated a lot of interest in my State of Vermont. I have been a strong supporter for a person's right to seek alternative approaches in medical care. It is clear that western medicine does not have all the answers. I am supportive of a new program which provides grants for alternative health research.

In September, we will be holding a conference in Vermont actually on cancer prevention looking at diet and the environmental

« ÀÌÀü°è¼Ó »